University of Sheffield and Parkinson's UK in new collaboration

The University of Sheffield and charity Parkinson’s UK are to collaborate on a new project to research and develop novel therapies for Parkinson’s disease, a condition which affects over 100,000 people in the UK.

A new ‘virtual biotech’ will be formed, named Keapstone Therapeutics, combining world-leading research from the university with funding and expertise from the charity.

Arthur Roach, director of research at Parkinson’s UK, said: “Due to the funding gap in early stage drug discovery, there are promising scientific breakthroughs for Parkinson’s happening every day that are not being picked up and developed by commercial companies.”